Notice of Participation of the National Institute of Dental and Craniofacial Research (NIDCR) in RFA-MD-22-004 Innovations for Healthy Living Improving Minority Health and Eliminating Health Disparities (R43/R44- Clinical Trial Optional)
Notice Number:
NOT-DE-22-004

Key Dates

Release Date:

January 25, 2022

Related Announcements

RFA-MD-22-004 - Innovations for Healthy Living- Improving Minority Health and Eliminating Health Disparities (R43/R44- Clinical Trial Optional)

Issued by

National Institute of Dental and Craniofacial Research (NIDCR)

Purpose

This Notice is to inform applicants that the National Institute of Dental and Craniofacial Research (NIDCR) has joined the Funding Opportunity Announcement (FOA) RFA-MD-22-004 Innovations for Healthy Living Improving Minority Health and Eliminating Health Disparities (R43/R44- Clinical Trial Optional)", effective immediately.

The following sections of RFA-MD-22-004 have been revised to reflect the participation of NIDCR in this FOA.

Currently Reads:

Part 1. Overview Information

Components of Participating Organizations

National Institute on Minority Health and Health Disparities (NIMHD)

National Heart, Lung, and Blood Institute (NHLBI)

National Institute on Aging (NIA)

National Institute of Biomedical Imaging and Bioengineering (NIBIB)

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

National Institute on Drug Abuse (NIDA)

National Institute of Mental Health (NIMH)

National Center for Advancing Translational Sciences (NCATS)

Catalog of Federal Domestic Assistance (CFDA) Number(s)

93.307, 93.847, 93.286, 93.350, 93.837, 93.838, 93.839, 93.840, 93.233, 93.866, 93.279, 93.242

Part 2. Full Text of Announcement

Section II. Award Information

Funds Available and Anticipated Number of Awards

The following NIH components intend to commit the following amounts in FY 2022 or 2023:

NIMHD, up to $1,000,000 total costs, 3-4 awards.

NHLBI, up to $2,900,000 total costs, 3 Phase I and one Direct-to-Phase II.

NIA, up to $1,000,000 total costs, 3-4 awards.

NIBIB, up to $1,000,000 total costs, 3-4 awards.

NIDA, up to $1,000,000 total costs, 1-3 awards.

NIMH, up to $250,000 total costs, 1 award.

NIDDK, up to $1,000,000 total costs, 1-3 awards.

Modified to Read (changes shown in bold italics):

Part 1. Overview Information

Components of Participating Organizations

National Institute on Minority Health and Health Disparities (NIMHD)

National Heart, Lung, and Blood Institute (NHLBI)

National Institute on Aging (NIA)

National Institute of Biomedical Imaging and Bioengineering (NIBIB)

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

National Institute on Drug Abuse (NIDA)

National Institute of Mental Health (NIMH)

National Center for Advancing Translational Sciences (NCATS)

National Institute of Dental and Craniofacial Research (NIDCR)

Catalog of Federal Domestic Assistance (CFDA) Number(s)

93.307, 93.847, 93.286, 93.350, 93.837, 93.838, 93.839, 93.840, 93.233, 93.866, 93.279, 93.242, 93.121

Part 2. Full Text of Announcement

Section II. Award Information

Funds Available and Anticipated Number of Awards

The following NIH components intend to commit the following amounts in FY 2022 or 2023:

NIMHD, up to $1,000,000 total costs, 3-4 awards.

NHLBI, up to $2,900,000 total costs, 3 Phase I and one Direct-to-Phase II.

NIA, up to $1,000,000 total costs, 3-4 awards.

NIBIB, up to $1,000,000 total costs, 3-4 awards.

NIDA, up to $1,000,000 total costs, 1-3 awards.

NIMH, up to $250,000 total costs, 1 award.

NIDDK, up to $1,000,000 total costs, 1-3 awards.

NIDCR, up to $250,000 total costs, 1 award.

Further, the following section of RFA-MD-22-004 has been updated to add the NIDCR Funding Opportunity Description:

Part 2. Full Text of Announcement

Section I. Funding Opportunity Description

Specific Areas of Research Interest for NIDCR:

NIDCR is interested in supporting development of technologies and products that promote dental, oral, and craniofacial (DOC) health equity and enhance effectiveness, acceptability, affordability, and sustainability of DOC health care and self-management among population groups disproportionately affected by DOC diseases and conditions. NIDCR’s areas interest include but are not limited to:

  • Enhancing efficiency, quality, and patient-centeredness in team-based DOC health care
  • Detecting, measuring, and assessing structural racism and discriminations in DOC health system
  • Creating and testing statistical models or tailored algorithms etc. to predict DOC health risks taking into account the influence of social determinants of health to advance personalized DOC health care and the financing strategies
  • Creating community-level opportunities to address DOC health determinants and enable DOC health promoting lifestyle in underserved communities
  • Aiding long-term adherence to DOC health recommendations and self-management capacity

All other aspects of the FOA remain the same.

Inquiries

Please direct all inquiries to:

Scientific/Research Contact(s)

Orlando Lopez, PhD
National Institute of Dental and Craniofacial Research (NIDCR)
Telephone: 301-402-4243
Email: [email protected]

Hiroko Iida, DDS, MPH
National Institute of Dental and Craniofacial Research (NIDCR)
Telephone: 301-594-7404
Email: [email protected]

Financial/Grants Management Contact(s)

Diana Rutberg, MBA
National Institute of Dental and Craniofacial Research (NIDCR)
Telephone: 301-594-4798
Email: [email protected]


Weekly TOC for this Announcement
NIH Funding Opportunities and Notices